Skip to main content
. 2022 Apr 25;13:886824. doi: 10.3389/fendo.2022.886824

Table 3.

Demographic, anthropometric and medical, lifestyle habits, adherence to the Mediterranean diet, and sleep quality of participants stratified by severity of menopausal symptoms (MRS).

Parameters None-to moderate symptoms
(n=11)
Marked Symptoms
(n=12)
Severe Symptoms
(n=77)
p-value*
Age (years) 61.0 ± 5.3 57.8 ± 8.5 56.5 ± 7.3 0.143
BMI (Kg/m2) 33.5 ± 4.4 34.0 ± 3.5 35.4 ± 5.8 0.450
Grade I obesity 8 (73%) 8 (67%) 49 (64%) 0.833
Grade II obesity 2 (18%) 3 (25%) 13 (17%) 0.793
Grade III obesity 1 (9%) 1 (8%) 15 (19%) 0.481
WC (cm) 105 ± 11 102 ± 8.9 109 ± 14 0.458
HC (cm) 114 ± 9.3 124 ± 16 124 ± 16 0.102
WHR 0.93 ± 0.10 0.90 ± 0.04 0.88 ± 0.05 0.208
Age at menarche (years) 12.2 ± 1.3 11.8 ± 1.4 11.7 ± 1.6 0.674
Age at menopause (years) 49.2 ± 4.4 49.5 ± 5.5 48.8 ± 4.7 0.896
Weight before menopause (kg) 76.6 ± 20 78.9 ± 12 82.9 ± 18 0.462
Weight gain after menopause (kg) 10.9 ± 13 12.9 ± 6.1 9.58 ± 15 0.734
Years since menopause 12.2 ± 6.5 9.67 ± 7.3 8.36 ± 8.7 0.350
Full-term pregnancies 2 (18%) 10 (83%) 67 (87%) 0.812
Menopause type
Natural menopause 10 (91%) 10 (83%) 67 (87%) 0.864
Induced menopause 1 (9%) 2 (17%) 10 (13%)
Diseases
Type 2 diabetes 0 (0%) 0 (0%) 8 (10%) 0.273
Hypertension 5 (45%) 5 (42%) 29 (38%) 0.867
Dyslipidemia 6 (54%) 4 (33%) 29 (38%) 0.512
Medications:
Antihypertensive 2 (18%) 6 (50%) 28 (36%) 0.281
Glucose-lowering drugs 2 (18%) 0 (0%) 4 (5%) 0.153
Statins 1 (1%) 0 (0%) 7 (9%) 0.553
Anticoagulant 2 (18%) 1 (8%) 4 (5%) 0.282
Smoking 2 (18%) 4 (33%) 17 (22%) 0.636
Alcohol intake 3 (27%) 1 (8%) 8 (10%) 0.250
Physical activity 2 (18%) 1 (8%) 18 (23%) 0.478
PREDIMED score 9.50 ± 0.7 7.08 ± 1.2a 7.83 ± 1.6 0.108
PSQI score 4.00 ± 1.4b 6.08 ± 2.9b 9.39 ± 3.5 0.001

Data are expressed as mean ± SD or n (%).

BMI, body mass index;WC, waist circumference; HC, hip circumference; WHR, waist-to-hip-ratio; PREDIMED, adherence to the Mediterranean diet (Prevención con Dieta Mediterránea); PSQI, Pittsburgh Sleep Quality Index.

*one-way ANOVA or chi-square test. ap < 0.05 vs. “none-to moderate symptoms” class, one-way ANOVA and at least difference (LSD) post hoc test for multiple comparisons. bp< 0.05 vs. “severe symptoms” class, one-way ANOVA and at least difference (LSD) post hoc test for multiple comparisons.